Molecular monitoring of 8p11 myeloproliferative syndrome in an infant

Wenyong W. Zhang, Sultan Habeebu, Andrea M. Sheehan, Rizwan C. Naeem, Vivian S. Hernandez, Zoann E. Dreyer, Dolores López-Terrada

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The 8p11 myeloproliferative syndrome is a rare hematologic malignancy derived from a pluripotent hematopoietic stem cell associated with rearrangements involving the fibroblast growth factor receptor 1 (FGFR1) gene located on chromosome 8p11. The most common translocation, t(8;13) (p11;q13), Results in a ZNF198-FGFR1 fusion gene and constitutively active FGFR1 tyrosine kinase activity. Typical pathologic findings include myeloid hyperplasia, lymphadenopathy, precursor T-lymphoblastic lymphoma, and eosinophilia. The disease is usually associated with an aggressive course and progression to acute myeloid leukemia is frequent. We report here the first case of 8p11 myeloproliferative syndrome in an infant and demonstrate the value of molecular testing in the diagnosis and minimal disease monitoring of this rare disease.

Original languageEnglish (US)
Pages (from-to)879-883
Number of pages5
JournalJournal of Pediatric Hematology/Oncology
Volume31
Issue number11
DOIs
StatePublished - Nov 2009
Externally publishedYes

Fingerprint

Receptor, Fibroblast Growth Factor, Type 1
Pluripotent Stem Cells
Gene Fusion
Eosinophilia
Hematologic Neoplasms
Rare Diseases
Hematopoietic Stem Cells
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acute Myeloid Leukemia
Protein-Tyrosine Kinases
Hyperplasia
Chromosomes
Genes

Keywords

  • EMS syndrome
  • Minimal disease monitoring
  • Molecular

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Zhang, W. W., Habeebu, S., Sheehan, A. M., Naeem, R. C., Hernandez, V. S., Dreyer, Z. E., & López-Terrada, D. (2009). Molecular monitoring of 8p11 myeloproliferative syndrome in an infant. Journal of Pediatric Hematology/Oncology, 31(11), 879-883. https://doi.org/10.1097/MPH.0b013e3181b83fd0

Molecular monitoring of 8p11 myeloproliferative syndrome in an infant. / Zhang, Wenyong W.; Habeebu, Sultan; Sheehan, Andrea M.; Naeem, Rizwan C.; Hernandez, Vivian S.; Dreyer, Zoann E.; López-Terrada, Dolores.

In: Journal of Pediatric Hematology/Oncology, Vol. 31, No. 11, 11.2009, p. 879-883.

Research output: Contribution to journalArticle

Zhang, WW, Habeebu, S, Sheehan, AM, Naeem, RC, Hernandez, VS, Dreyer, ZE & López-Terrada, D 2009, 'Molecular monitoring of 8p11 myeloproliferative syndrome in an infant', Journal of Pediatric Hematology/Oncology, vol. 31, no. 11, pp. 879-883. https://doi.org/10.1097/MPH.0b013e3181b83fd0
Zhang, Wenyong W. ; Habeebu, Sultan ; Sheehan, Andrea M. ; Naeem, Rizwan C. ; Hernandez, Vivian S. ; Dreyer, Zoann E. ; López-Terrada, Dolores. / Molecular monitoring of 8p11 myeloproliferative syndrome in an infant. In: Journal of Pediatric Hematology/Oncology. 2009 ; Vol. 31, No. 11. pp. 879-883.
@article{8a85b3247393499cb5dd4b3f1a43fd09,
title = "Molecular monitoring of 8p11 myeloproliferative syndrome in an infant",
abstract = "The 8p11 myeloproliferative syndrome is a rare hematologic malignancy derived from a pluripotent hematopoietic stem cell associated with rearrangements involving the fibroblast growth factor receptor 1 (FGFR1) gene located on chromosome 8p11. The most common translocation, t(8;13) (p11;q13), Results in a ZNF198-FGFR1 fusion gene and constitutively active FGFR1 tyrosine kinase activity. Typical pathologic findings include myeloid hyperplasia, lymphadenopathy, precursor T-lymphoblastic lymphoma, and eosinophilia. The disease is usually associated with an aggressive course and progression to acute myeloid leukemia is frequent. We report here the first case of 8p11 myeloproliferative syndrome in an infant and demonstrate the value of molecular testing in the diagnosis and minimal disease monitoring of this rare disease.",
keywords = "EMS syndrome, Minimal disease monitoring, Molecular",
author = "Zhang, {Wenyong W.} and Sultan Habeebu and Sheehan, {Andrea M.} and Naeem, {Rizwan C.} and Hernandez, {Vivian S.} and Dreyer, {Zoann E.} and Dolores L{\'o}pez-Terrada",
year = "2009",
month = "11",
doi = "10.1097/MPH.0b013e3181b83fd0",
language = "English (US)",
volume = "31",
pages = "879--883",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Molecular monitoring of 8p11 myeloproliferative syndrome in an infant

AU - Zhang, Wenyong W.

AU - Habeebu, Sultan

AU - Sheehan, Andrea M.

AU - Naeem, Rizwan C.

AU - Hernandez, Vivian S.

AU - Dreyer, Zoann E.

AU - López-Terrada, Dolores

PY - 2009/11

Y1 - 2009/11

N2 - The 8p11 myeloproliferative syndrome is a rare hematologic malignancy derived from a pluripotent hematopoietic stem cell associated with rearrangements involving the fibroblast growth factor receptor 1 (FGFR1) gene located on chromosome 8p11. The most common translocation, t(8;13) (p11;q13), Results in a ZNF198-FGFR1 fusion gene and constitutively active FGFR1 tyrosine kinase activity. Typical pathologic findings include myeloid hyperplasia, lymphadenopathy, precursor T-lymphoblastic lymphoma, and eosinophilia. The disease is usually associated with an aggressive course and progression to acute myeloid leukemia is frequent. We report here the first case of 8p11 myeloproliferative syndrome in an infant and demonstrate the value of molecular testing in the diagnosis and minimal disease monitoring of this rare disease.

AB - The 8p11 myeloproliferative syndrome is a rare hematologic malignancy derived from a pluripotent hematopoietic stem cell associated with rearrangements involving the fibroblast growth factor receptor 1 (FGFR1) gene located on chromosome 8p11. The most common translocation, t(8;13) (p11;q13), Results in a ZNF198-FGFR1 fusion gene and constitutively active FGFR1 tyrosine kinase activity. Typical pathologic findings include myeloid hyperplasia, lymphadenopathy, precursor T-lymphoblastic lymphoma, and eosinophilia. The disease is usually associated with an aggressive course and progression to acute myeloid leukemia is frequent. We report here the first case of 8p11 myeloproliferative syndrome in an infant and demonstrate the value of molecular testing in the diagnosis and minimal disease monitoring of this rare disease.

KW - EMS syndrome

KW - Minimal disease monitoring

KW - Molecular

UR - http://www.scopus.com/inward/record.url?scp=74249117077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74249117077&partnerID=8YFLogxK

U2 - 10.1097/MPH.0b013e3181b83fd0

DO - 10.1097/MPH.0b013e3181b83fd0

M3 - Article

VL - 31

SP - 879

EP - 883

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 11

ER -